Clinical trial

Docetaxel Ethanol-induced Symptoms; The Incidence and Risk Forecating Factor

NCT04545632

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2020-06-10

PhaseN/A

Study timeline

Study start (actual)2020-06-10Date precision: day

Registry last updated2022-07-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

NSCLCunresolved

Prostate Cancerunresolved

Head and Neck Cancerunresolved

Gastric Cancerunresolved

Esophageal Cancerunresolved

Ovarian Cancerunresolved

Interventions

Sponsors & collaborators

Boryung Pharmaceutical Co., Ltdlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04545632 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.